12 hours Arcturus Gears Up to Report Q3 Earnings: Here’s What to ExpectZacks
On ARCT’s third-quarter 2024 earnings call, investors’ focus is likely to be on the upcoming launch of its COVID-19 vaccine, Kostaive and other pipeline updates.
Coronavirus · Earnings · Moderna (MRNA)
X